世界の腫瘍マーカーイムノアッセイ市場2026:インサイト・予測

QYResearchが発行した調査報告書(QYR20NV04907)
◆英語タイトル:Global Tumor Markers Immunoassay Market Size, Status and Forecast 2020-2026
◆商品コード:QYR20NV04907
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年11月(※2024年版があります。お問い合わせください。)
◆ページ数:133
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは腫瘍マーカーイムノアッセイの世界市場について調査・分析した資料です。種類別(ProGRP、PSA(複合体、遊離、合計))、SCC(扁平上皮癌抗原)、血清HER-2 / neu、サイログロブリン、CA 72-4、その他)の市場規模、用途別(肝臓がん、乳がん、その他)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別腫瘍マーカーイムノアッセイの競争状況、市場シェア
・世界の腫瘍マーカーイムノアッセイ市場:種類別市場規模 2015年-2020年(ProGRP、PSA(複合体、遊離、合計))、SCC(扁平上皮癌抗原)、血清HER-2 / neu、サイログロブリン、CA 72-4、その他)
・世界の腫瘍マーカーイムノアッセイ市場:種類別市場規模予測 2021年-2026年(ProGRP、PSA(複合体、遊離、合計))、SCC(扁平上皮癌抗原)、血清HER-2 / neu、サイログロブリン、CA 72-4、その他)
・世界の腫瘍マーカーイムノアッセイ市場:用途別市場規模 2015年-2020年(肝臓がん、乳がん、その他)
・世界の腫瘍マーカーイムノアッセイ市場:用途別市場規模予測 2021年-2026年(肝臓がん、乳がん、その他)
・北米の腫瘍マーカーイムノアッセイ市場分析:米国、カナダ
・ヨーロッパの腫瘍マーカーイムノアッセイ市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの腫瘍マーカーイムノアッセイ市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の腫瘍マーカーイムノアッセイ市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの腫瘍マーカーイムノアッセイ市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Clarity Diagnostics, LLC、CTK Biotech, Inc、DIALAB GmbH、Ortho Clinical Diagnostics、Polymedco, Inc、DIAsource ImmunoAssays SA、DRG International, Inc、Fujirebio US, Inc、Bioscience (Tianjin) Diagnostic Technology Co., Ltd、Boson Biotech Co., Ltd、Qualigen, Inc、Randox Laboratories, Ltd、Roche Diagnostic Corporation、Siemens Healthineers、Syntron Bioresearch, Inc、Teco Diagnostics、Thermo Fisher Scientific, Inc、Tosoh Bioscience, Inc、Diametra、DiaSorin S.p.A
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Market Analysis and Insights: Global Tumor Markers Immunoassay Market
The global Tumor Markers Immunoassay market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Tumor Markers Immunoassay Scope and Market Size
Tumor Markers Immunoassay market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Tumor Markers Immunoassay market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Clarity Diagnostics, LLC
CTK Biotech, Inc
DIALAB GmbH
Ortho Clinical Diagnostics
Polymedco, Inc
DIAsource ImmunoAssays SA
DRG International, Inc
Fujirebio US, Inc
Bioscience (Tianjin) Diagnostic Technology Co., Ltd
Boson Biotech Co., Ltd
Qualigen, Inc
Randox Laboratories, Ltd
Roche Diagnostic Corporation
Siemens Healthineers
Syntron Bioresearch, Inc
Teco Diagnostics
Thermo Fisher Scientific, Inc
Tosoh Bioscience, Inc
Diametra
DiaSorin S.p.A

Market segment by Type, the product can be split into
ProGRP
PSA (complexed, free, total))
SCC (squamous cell carcinoma antigen)
Serum HER-2/neu
Thyroglobulin
CA 72-4
Others
Market segment by Application, split into
Liver Cancer
Breast Cancer
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Tumor Markers Immunoassay Revenue
1.4 Market by Type
1.4.1 Global Tumor Markers Immunoassay Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 ProGRP
1.4.3 PSA (complexed, free, total))
1.4.4 SCC (squamous cell carcinoma antigen)
1.4.5 Serum HER-2/neu
1.4.6 Thyroglobulin
1.4.7 CA 72-4
1.4.8 Others
1.5 Market by Application
1.5.1 Global Tumor Markers Immunoassay Market Share by Application: 2020 VS 2026
1.5.2 Liver Cancer
1.5.3 Breast Cancer
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Tumor Markers Immunoassay Market Perspective (2015-2026)
2.2 Global Tumor Markers Immunoassay Growth Trends by Regions
2.2.1 Tumor Markers Immunoassay Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Tumor Markers Immunoassay Historic Market Share by Regions (2015-2020)
2.2.3 Tumor Markers Immunoassay Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Tumor Markers Immunoassay Market Growth Strategy
2.3.6 Primary Interviews with Key Tumor Markers Immunoassay Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Tumor Markers Immunoassay Players by Market Size
3.1.1 Global Top Tumor Markers Immunoassay Players by Revenue (2015-2020)
3.1.2 Global Tumor Markers Immunoassay Revenue Market Share by Players (2015-2020)
3.1.3 Global Tumor Markers Immunoassay Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Tumor Markers Immunoassay Market Concentration Ratio
3.2.1 Global Tumor Markers Immunoassay Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Tumor Markers Immunoassay Revenue in 2019
3.3 Tumor Markers Immunoassay Key Players Head office and Area Served
3.4 Key Players Tumor Markers Immunoassay Product Solution and Service
3.5 Date of Enter into Tumor Markers Immunoassay Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Tumor Markers Immunoassay Historic Market Size by Type (2015-2020)
4.2 Global Tumor Markers Immunoassay Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Tumor Markers Immunoassay Market Size by Application (2015-2020)
5.2 Global Tumor Markers Immunoassay Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Tumor Markers Immunoassay Market Size (2015-2020)
6.2 Tumor Markers Immunoassay Key Players in North America (2019-2020)
6.3 North America Tumor Markers Immunoassay Market Size by Type (2015-2020)
6.4 North America Tumor Markers Immunoassay Market Size by Application (2015-2020)

7 Europe
7.1 Europe Tumor Markers Immunoassay Market Size (2015-2020)
7.2 Tumor Markers Immunoassay Key Players in Europe (2019-2020)
7.3 Europe Tumor Markers Immunoassay Market Size by Type (2015-2020)
7.4 Europe Tumor Markers Immunoassay Market Size by Application (2015-2020)

8 China
8.1 China Tumor Markers Immunoassay Market Size (2015-2020)
8.2 Tumor Markers Immunoassay Key Players in China (2019-2020)
8.3 China Tumor Markers Immunoassay Market Size by Type (2015-2020)
8.4 China Tumor Markers Immunoassay Market Size by Application (2015-2020)

9 Japan
9.1 Japan Tumor Markers Immunoassay Market Size (2015-2020)
9.2 Tumor Markers Immunoassay Key Players in Japan (2019-2020)
9.3 Japan Tumor Markers Immunoassay Market Size by Type (2015-2020)
9.4 Japan Tumor Markers Immunoassay Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Tumor Markers Immunoassay Market Size (2015-2020)
10.2 Tumor Markers Immunoassay Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Tumor Markers Immunoassay Market Size by Type (2015-2020)
10.4 Southeast Asia Tumor Markers Immunoassay Market Size by Application (2015-2020)

11 India
11.1 India Tumor Markers Immunoassay Market Size (2015-2020)
11.2 Tumor Markers Immunoassay Key Players in India (2019-2020)
11.3 India Tumor Markers Immunoassay Market Size by Type (2015-2020)
11.4 India Tumor Markers Immunoassay Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Tumor Markers Immunoassay Market Size (2015-2020)
12.2 Tumor Markers Immunoassay Key Players in Central & South America (2019-2020)
12.3 Central & South America Tumor Markers Immunoassay Market Size by Type (2015-2020)
12.4 Central & South America Tumor Markers Immunoassay Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Clarity Diagnostics, LLC
13.1.1 Clarity Diagnostics, LLC Company Details
13.1.2 Clarity Diagnostics, LLC Business Overview
13.1.3 Clarity Diagnostics, LLC Tumor Markers Immunoassay Introduction
13.1.4 Clarity Diagnostics, LLC Revenue in Tumor Markers Immunoassay Business (2015-2020))
13.1.5 Clarity Diagnostics, LLC Recent Development
13.2 CTK Biotech, Inc
13.2.1 CTK Biotech, Inc Company Details
13.2.2 CTK Biotech, Inc Business Overview
13.2.3 CTK Biotech, Inc Tumor Markers Immunoassay Introduction
13.2.4 CTK Biotech, Inc Revenue in Tumor Markers Immunoassay Business (2015-2020)
13.2.5 CTK Biotech, Inc Recent Development
13.3 DIALAB GmbH
13.3.1 DIALAB GmbH Company Details
13.3.2 DIALAB GmbH Business Overview
13.3.3 DIALAB GmbH Tumor Markers Immunoassay Introduction
13.3.4 DIALAB GmbH Revenue in Tumor Markers Immunoassay Business (2015-2020)
13.3.5 DIALAB GmbH Recent Development
13.4 Ortho Clinical Diagnostics
13.4.1 Ortho Clinical Diagnostics Company Details
13.4.2 Ortho Clinical Diagnostics Business Overview
13.4.3 Ortho Clinical Diagnostics Tumor Markers Immunoassay Introduction
13.4.4 Ortho Clinical Diagnostics Revenue in Tumor Markers Immunoassay Business (2015-2020)
13.4.5 Ortho Clinical Diagnostics Recent Development
13.5 Polymedco, Inc
13.5.1 Polymedco, Inc Company Details
13.5.2 Polymedco, Inc Business Overview
13.5.3 Polymedco, Inc Tumor Markers Immunoassay Introduction
13.5.4 Polymedco, Inc Revenue in Tumor Markers Immunoassay Business (2015-2020)
13.5.5 Polymedco, Inc Recent Development
13.6 DIAsource ImmunoAssays SA
13.6.1 DIAsource ImmunoAssays SA Company Details
13.6.2 DIAsource ImmunoAssays SA Business Overview
13.6.3 DIAsource ImmunoAssays SA Tumor Markers Immunoassay Introduction
13.6.4 DIAsource ImmunoAssays SA Revenue in Tumor Markers Immunoassay Business (2015-2020)
13.6.5 DIAsource ImmunoAssays SA Recent Development
13.7 DRG International, Inc
13.7.1 DRG International, Inc Company Details
13.7.2 DRG International, Inc Business Overview
13.7.3 DRG International, Inc Tumor Markers Immunoassay Introduction
13.7.4 DRG International, Inc Revenue in Tumor Markers Immunoassay Business (2015-2020)
13.7.5 DRG International, Inc Recent Development
13.8 Fujirebio US, Inc
13.8.1 Fujirebio US, Inc Company Details
13.8.2 Fujirebio US, Inc Business Overview
13.8.3 Fujirebio US, Inc Tumor Markers Immunoassay Introduction
13.8.4 Fujirebio US, Inc Revenue in Tumor Markers Immunoassay Business (2015-2020)
13.8.5 Fujirebio US, Inc Recent Development
13.9 Bioscience (Tianjin) Diagnostic Technology Co., Ltd
13.9.1 Bioscience (Tianjin) Diagnostic Technology Co., Ltd Company Details
13.9.2 Bioscience (Tianjin) Diagnostic Technology Co., Ltd Business Overview
13.9.3 Bioscience (Tianjin) Diagnostic Technology Co., Ltd Tumor Markers Immunoassay Introduction
13.9.4 Bioscience (Tianjin) Diagnostic Technology Co., Ltd Revenue in Tumor Markers Immunoassay Business (2015-2020)
13.9.5 Bioscience (Tianjin) Diagnostic Technology Co., Ltd Recent Development
13.10 Boson Biotech Co., Ltd
13.10.1 Boson Biotech Co., Ltd Company Details
13.10.2 Boson Biotech Co., Ltd Business Overview
13.10.3 Boson Biotech Co., Ltd Tumor Markers Immunoassay Introduction
13.10.4 Boson Biotech Co., Ltd Revenue in Tumor Markers Immunoassay Business (2015-2020)
13.10.5 Boson Biotech Co., Ltd Recent Development
13.11 Qualigen, Inc
10.11.1 Qualigen, Inc Company Details
10.11.2 Qualigen, Inc Business Overview
10.11.3 Qualigen, Inc Tumor Markers Immunoassay Introduction
10.11.4 Qualigen, Inc Revenue in Tumor Markers Immunoassay Business (2015-2020)
10.11.5 Qualigen, Inc Recent Development
13.12 Randox Laboratories, Ltd
10.12.1 Randox Laboratories, Ltd Company Details
10.12.2 Randox Laboratories, Ltd Business Overview
10.12.3 Randox Laboratories, Ltd Tumor Markers Immunoassay Introduction
10.12.4 Randox Laboratories, Ltd Revenue in Tumor Markers Immunoassay Business (2015-2020)
10.12.5 Randox Laboratories, Ltd Recent Development
13.13 Roche Diagnostic Corporation
10.13.1 Roche Diagnostic Corporation Company Details
10.13.2 Roche Diagnostic Corporation Business Overview
10.13.3 Roche Diagnostic Corporation Tumor Markers Immunoassay Introduction
10.13.4 Roche Diagnostic Corporation Revenue in Tumor Markers Immunoassay Business (2015-2020)
10.13.5 Roche Diagnostic Corporation Recent Development
13.14 Siemens Healthineers
10.14.1 Siemens Healthineers Company Details
10.14.2 Siemens Healthineers Business Overview
10.14.3 Siemens Healthineers Tumor Markers Immunoassay Introduction
10.14.4 Siemens Healthineers Revenue in Tumor Markers Immunoassay Business (2015-2020)
10.14.5 Siemens Healthineers Recent Development
13.15 Syntron Bioresearch, Inc
10.15.1 Syntron Bioresearch, Inc Company Details
10.15.2 Syntron Bioresearch, Inc Business Overview
10.15.3 Syntron Bioresearch, Inc Tumor Markers Immunoassay Introduction
10.15.4 Syntron Bioresearch, Inc Revenue in Tumor Markers Immunoassay Business (2015-2020)
10.15.5 Syntron Bioresearch, Inc Recent Development
13.16 Teco Diagnostics
10.16.1 Teco Diagnostics Company Details
10.16.2 Teco Diagnostics Business Overview
10.16.3 Teco Diagnostics Tumor Markers Immunoassay Introduction
10.16.4 Teco Diagnostics Revenue in Tumor Markers Immunoassay Business (2015-2020)
10.16.5 Teco Diagnostics Recent Development
13.17 Thermo Fisher Scientific, Inc
10.17.1 Thermo Fisher Scientific, Inc Company Details
10.17.2 Thermo Fisher Scientific, Inc Business Overview
10.17.3 Thermo Fisher Scientific, Inc Tumor Markers Immunoassay Introduction
10.17.4 Thermo Fisher Scientific, Inc Revenue in Tumor Markers Immunoassay Business (2015-2020)
10.17.5 Thermo Fisher Scientific, Inc Recent Development
13.18 Tosoh Bioscience, Inc
10.18.1 Tosoh Bioscience, Inc Company Details
10.18.2 Tosoh Bioscience, Inc Business Overview
10.18.3 Tosoh Bioscience, Inc Tumor Markers Immunoassay Introduction
10.18.4 Tosoh Bioscience, Inc Revenue in Tumor Markers Immunoassay Business (2015-2020)
10.18.5 Tosoh Bioscience, Inc Recent Development
13.19 Diametra
10.19.1 Diametra Company Details
10.19.2 Diametra Business Overview
10.19.3 Diametra Tumor Markers Immunoassay Introduction
10.19.4 Diametra Revenue in Tumor Markers Immunoassay Business (2015-2020)
10.19.5 Diametra Recent Development
13.20 DiaSorin S.p.A
10.20.1 DiaSorin S.p.A Company Details
10.20.2 DiaSorin S.p.A Business Overview
10.20.3 DiaSorin S.p.A Tumor Markers Immunoassay Introduction
10.20.4 DiaSorin S.p.A Revenue in Tumor Markers Immunoassay Business (2015-2020)
10.20.5 DiaSorin S.p.A Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

...

【掲載企業】

Clarity Diagnostics, LLC、CTK Biotech, Inc、DIALAB GmbH、Ortho Clinical Diagnostics、Polymedco, Inc、DIAsource ImmunoAssays SA、DRG International, Inc、Fujirebio US, Inc、Bioscience (Tianjin) Diagnostic Technology Co., Ltd、Boson Biotech Co., Ltd、Qualigen, Inc、Randox Laboratories, Ltd、Roche Diagnostic Corporation、Siemens Healthineers、Syntron Bioresearch, Inc、Teco Diagnostics、Thermo Fisher Scientific, Inc、Tosoh Bioscience, Inc、Diametra、DiaSorin S.p.A

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の腫瘍マーカーイムノアッセイ市場2026:インサイト・予測(Global Tumor Markers Immunoassay Market Size, Status and Forecast 2020-2026)]についてメールでお問い合わせはこちらでお願いします。